State Of Wyoming Bluebird Bio, Inc. Transaction History

State Of Wyoming

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.94 - $5.23 $8,170 - $14,534	-2,779 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$4.07 - $10.6 $10,765 - $28,037	2,645 Added 1973.88%	2,779 $14,000
Q4 2021 Feb 11, 2022	SELL	$8.96 - $16.31 $9,703 - $17,663	-1,083 Reduced 88.99%	134 $1,000
Q3 2021 Feb 11, 2022	BUY	$11.24 - $21.0 $10,543 - $19,698	938 Added 336.2%	1,217 $23,000
Q2 2021 Feb 11, 2022	BUY	$18.04 - $22.09 $4,870 - $5,964	270 Added 3000.0%	279 $9,000
Q1 2021 Feb 08, 2022	BUY	$16.59 - $33.89 $149 - $305	9 New	9 $0

162

79.9M

525K

634K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $38.6M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.